# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T15:37:11.867767
**Route:** OpenRouter + LaTeX
**Tokens:** 20977 in / 996 out
**Response SHA256:** c21571388a2ec804

---

I reviewed the draft for fatal errors in the four allowed categories (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I inspected all tables, figures, treatment timing, sample-period statements, regression outputs, and appendix material.

Finding: I found no fatal errors.

Notes supporting the PASS decision (non-exhaustive, for your checking, not flagged as fatal):
- Treatment timing vs. data coverage: The paper consistently treats Colorado (2021), Connecticut/Nevada (2022), Rhode Island/CA/WA (2023) as cohorts with post-treatment exposure through income year 2023, and correctly notes New York and Hawaii as first-income-year-2024 cohorts with no post-treatment observations in the sample. The stated CPS ASEC window (surveys 2015–2024 corresponding to income years 2014–2023) and the mapping from law effective dates to first income year are internally consistent.
- Regression outputs: SEs, coefficients, and R² values in presented tables are within plausible ranges for the reported outcomes (log wages). No NA/Inf/negative-SE/R²-out-of-bounds values appear. Standard errors and coefficients do not exhibit the implausible magnitudes flagged as fatal in the rubric.
- Completeness: No placeholder strings (TBD/NA/XXX) or empty numeric cells; sample sizes and standard errors are reported; references to figures/tables appear present; robustness and placebo checks are reported.
- Internal consistency: Numbers cited in text match table values (e.g., ATT magnitudes), treatment/cohort counts and weights are described consistently (paper clarifies which cohorts have no post-treatment years), and specification descriptions match column headers.

Verdict: ADVISOR VERDICT: PASS